Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation

Clinical Trial ID NCT00684307

Rank	Title	Journal	Year	PubWeight™‹?›
1	Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists.	Eur Heart J	2009	1.57
2	Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies.	Europace	2013	1.53
3	Exposure-response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation.	Br J Clin Pharmacol	2015	0.75